Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Viveve Medical Inc. (VIVE:NASDAQ), powered by AI.
Viveve Medical Inc. is currently trading at $0.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Viveve Medical Inc. on Alpha Lenz.
Viveve Medical Inc.'s P/E ratio is -0.0.
“Viveve Medical Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -202.2%.”
Ask for details →Viveve Medical Inc. specializes in the design, development, manufacturing, and marketing of medical devices primarily focused on women's health. Its flagship product, the Viveve System, employs Cryogen-cooled Monopolar Radiofrequency technology for non-invasive treatments addressing vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. This innovative medical technology plays a significant role in enhancing women's well-being by offering low-risk, high-reward procedures. Viveve Medical Inc. operates across a global network, including the Americas, Europe, and Asia-Pacific regions, making it a notable player in the healthcare sector, particularly within the medical devices industry.
“Viveve Medical Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -202.2%.”
Ask for details →